News >

PARP Inhibition Arrives in Pancreatic Cancer

Danielle Ternyila
Published: Thursday, Aug 08, 2019

Michael J. Hall, MD, Fox Chase Cancer Center

Michael J. Hall, MD

PARP inhibitors, which have approved indications in breast and ovarian cancer, are expanding to additional treatment paradigms, including pancreatic cancer.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication